THE LATEST
NovaQuest provides structured finance for Phase III pharma partners
The influx of PE investment in drug development is 'great evidence of the need for capital solutions for the life sciences,' said NovaQuest’s Patrick Jordan.
DAILY INSIGHTS
TECH WATCH
HEALTHCARE
NEWS IN BRIEF
VOX POPULI
Teamwork in private equity: not always what you might expect
When private equity firms look to make acquisitions for their portfolio companies, they often assess potential targets through a standard organizational lens.
Seemingly unsexy PE holdings may be your next unicorns
Rather than desperately searching for the next elusive unicorn, PE fund managers might instead have better luck looking at what’s already sitting in their portfolios.
Growth will depend on operational strategy
Private equity success will be predicated on balancing record growth and new deals with better risk management, improved visibility and optimized supply chains.